Concepedia

Kikumi Tsuda

KT

Statistics

Publications

3

Citations

92

H-Index

3

Active since

2017

Affiliations

Mitsubishi Corporation (United States)(Current)

Mitsubishi Tanabe Pharma Corporation

Kikumi Tsuda is an author at Mitsubishi Corporation (United States) specializing in neurology, neuroscience, and medicine.

Top concepts

Publications per year

2017–2017

3

Publications

3

Post-hoc analysis of MCI186-17, the extension study to MCI186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis

Fumihiro Takahashi, Koji Takei, Kikumi Tsuda et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2017 · 39 citations · Full text

, , +20

Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis

Koji Takei, Fumihiro Takahashi, X. Shawn Liu et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2017 · 32 citations · Full text

, , +15

Post-hoc analysis of open-label extension period of study MCI186-19 in amyotrophic lateral sclerosis

Koji Takei, Kikumi Tsuda, Fumihiro Takahashi et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2017 · 21 citations · Full text

1–3 of 3